Morning Report 19 Nov 20: US sharemarkets declined on Wednesday

New York City and Chicago announced fresh restrictions to curb the spread of coronavirus. Pfizer (+0.8%) and its partner BioNTech (+4%) revealed a 95% success rate at the conclusion of their COVID-19 vaccine trial. Retailer Lowe's shares dipped 8.2% after its earnings missed analysts' expectations. Shares of Target (+2.3%) advanced on soaring sales. Boeing shares fell 3.2%, despite the Federal Aviation Administration lifting its ban on the 737 Max aircraft. The Dow Jones index closed lower by 345 points or 1.2% after rising as much as 147 points at session highs. The S&P 500 index was also down 1.2%. And the Nasdaq index fell by 98 points or 0.8%.     

This report is approved and distributed in Australia by Commonwealth Securities Limited ABN 60 067 254 399, AFSL 238814 (CommSec) a wholly owned but non-guaranteed subsidiary of Commonwealth Bank of Australia ABN 48 123 123 124, AFSL 234945 (the Bank). The Bank and its subsidiaries have effected or may effect transactions for their own account in any investments or related investments referred to in this report. This report is not a recommendation to buy, sell or hold any securities or financial products, and has been prepared without taking account of the objectives, financial or taxation situation or needs of any particular individual. For this reason, any individual should, before acting on the information in this report, consider the appropriateness of the information, having regard to the individual's objectives, financial or taxation situation and needs and, if necessary, seek appropriate professional advice. This report is produced by Commonwealth Research based on information available at the time of publishing. We believe that the information in this correspondence is correct and any opinions, conclusions or recommendations are reasonably held or made as at the time of its compilation, but no warranty is made as to accuracy, reliability or completeness. To the extent permitted by law, neither the Bank nor any of its subsidiaries accept liability to any person for loss or damage arising from the use of this report.